Ian Campbell

28.0k total citations · 2 hit papers
245 papers, 11.0k citations indexed

About

Ian Campbell is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ian Campbell has authored 245 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 78 papers in Cancer Research and 77 papers in Genetics. Recurrent topics in Ian Campbell's work include Cancer Genomics and Diagnostics (58 papers), BRCA gene mutations in cancer (46 papers) and Ovarian cancer diagnosis and treatment (34 papers). Ian Campbell is often cited by papers focused on Cancer Genomics and Diagnostics (58 papers), BRCA gene mutations in cancer (46 papers) and Ovarian cancer diagnosis and treatment (34 papers). Ian Campbell collaborates with scholars based in Australia, United Kingdom and United States. Ian Campbell's co-authors include David Y.H. Choong, William D. Foulkes, Kylie L. Gorringe, Izhak Haviv, John Trowsdale, Kornélia Polyák, Wayne A. Phillips, Andrew Hitchcock, Ella R. Thompson and Karen G. Montgomery and has published in prestigious journals such as Nature, Nature Communications and Nature Genetics.

In The Last Decade

Ian Campbell

237 papers receiving 10.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutation of the PIK3CA Gene in Ovarian and Breast Cancer

2004 740 citations Ian Campbell, David Y.H. Choong et al. Cancer Research profile →
Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample recommendations

2007 671 citations Ian Campbell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Campbell Australia	54	5.4k	2.9k	2.6k	1.9k	1.8k	245	11.0k
Mark H. Greene United States	49	3.2k 0.6×	3.5k 1.2×	1.3k 0.5×	2.3k 1.2×	860 0.5×	198	9.6k
Pamela J. Russell Australia	61	4.2k 0.8×	2.4k 0.8×	1.5k 0.6×	996 0.5×	1.6k 0.9×	341	11.7k
Ben Davidson Norway	63	6.9k 1.3×	3.8k 1.3×	3.6k 1.4×	584 0.3×	2.4k 1.4×	420	13.7k
Zhibin Hu China	59	9.9k 1.8×	2.5k 0.9×	7.1k 2.7×	1.6k 0.9×	880 0.5×	499	17.4k
Anthony J. Swerdlow United Kingdom	73	3.0k 0.6×	5.6k 1.9×	1.3k 0.5×	2.9k 1.6×	1.1k 0.6×	283	16.9k
Håkan Olsson Sweden	67	4.2k 0.8×	5.8k 2.0×	3.6k 1.4×	4.7k 2.6×	1.1k 0.6×	453	15.7k
D. Wallwiener Germany	54	2.5k 0.5×	5.0k 1.7×	3.4k 1.3×	1.3k 0.7×	1.4k 0.8×	608	12.8k
Charles W. Drescher United States	43	7.4k 1.4×	1.7k 0.6×	6.4k 2.4×	859 0.5×	2.0k 1.1×	113	11.9k
Takayuki Enomoto Japan	52	2.6k 0.5×	2.6k 0.9×	1.5k 0.6×	816 0.4×	2.8k 1.5×	369	9.1k
Michael Quinn Australia	61	3.0k 0.6×	3.7k 1.3×	1.3k 0.5×	933 0.5×	3.2k 1.8×	342	12.7k

Countries citing papers authored by Ian Campbell

Since Specialization

Citations

This map shows the geographic impact of Ian Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Campbell more than expected).

Fields of papers citing papers by Ian Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Campbell. The network helps show where Ian Campbell may publish in the future.

Co-authorship network of co-authors of Ian Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Campbell. A scholar is included among the top collaborators of Ian Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Campbell. Ian Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawrenson, Ross, et al.. (2025). Challenges and opportunities for Aotearoa/New Zealand's breast screening programme. Journal of the Royal Society of New Zealand. 55(5). 1295–1303.

Pishas, Kathleen I., Simone McInerny, Simone M. Rowley, et al.. (2025). Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing. npj Genomic Medicine. 10(1). 1–1.

Lawrenson, Ross, et al.. (2024). Ethnic differences in time to surgery for women with early stage breast cancer in Aotearoa/New Zealand: a population-based study. The Lancet Regional Health - Western Pacific. 47. 101091–101091.

Krishnasamy, Mei, Senthil Lingaratnam, Sam Harris, et al.. (2023). Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey. Clinical and Translational Science. 16(12). 2700–2708. 2 indexed citations

Keogh, Louise, et al.. (2023). Impact of a risk based breast screening decision aid on understanding, acceptance and decision making. npj Breast Cancer. 9(1). 65–65. 4 indexed citations

Campbell, Ian, et al.. (2023). Maturational trend of daytime sleep propensity in adolescents. SLEEP. 47(1). 5 indexed citations

Tiller, Jane, Rajneesh Kaur, Simone M. Rowley, et al.. (2022). Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study. Journal of Medical Genetics. 60(3). 265–273. 5 indexed citations

Li, Na, Simone McInerny, Magnus Zethoven, et al.. (2022). Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. JNCI Journal of the National Cancer Institute. 115(2). 181–189. 6 indexed citations

Tiller, Jane, Bettina Meiser, Kristine Barlow‐Stewart, et al.. (2021). Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper. BMJ Open. 11(6). e041186–e041186. 2 indexed citations

10.

Li, Na, Simone McInerny, Magnus Zethoven, et al.. (2019). Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer. JNCI Journal of the National Cancer Institute. 111(12). 1332–1338. 23 indexed citations

11.

Alexiadis, Maria, Simone M. Rowley, Simon Chu, et al.. (2018). Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing. Molecular Cancer Research. 17(1). 177–185. 42 indexed citations

12.

Eccles, Diana, Na Li, Tom Maishman, et al.. (2015). Genetic testing in a cohort of young patients with HER2-amplified breast cancer. Annals of Oncology. 27(3). 467–473. 20 indexed citations

13.

Sheppard, Karen E., et al.. (2013). Functional Analysis of Genes in Regions Commonly Amplified in High-Grade Serous and Endometrioid Ovarian Cancer. Clinical Cancer Research. 19(6). 1411–1421. 51 indexed citations

14.

Hunter, Sally M., Kylie L. Gorringe, Michael Christie, et al.. (2012). Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations. Clinical Cancer Research. 18(19). 5267–5277. 52 indexed citations

15.

Hunter, Sally M., Michael S. Anglesio, Raghwa Sharma, et al.. (2011). Copy Number Aberrations in Benign Serous Ovarian Tumors: A Case for Reclassification?. Clinical Cancer Research. 17(23). 7273–7282. 17 indexed citations

16.

Mitchell, Gillian, Sandra Johnson, Lisa Devereux, et al.. (2010). Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 19(1). 265–274. 22 indexed citations

17.

Jacobs, Sharoni, Ella R. Thompson, Yasuhito Nannya, et al.. (2007). Genome-Wide, High-Resolution Detection of Copy Number, Loss of Heterozygosity, and Genotypes from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Microarrays. Cancer Research. 67(6). 2544–2551. 65 indexed citations

18.

Gorringe, Kylie L., Sharoni Jacobs, Ella R. Thompson, et al.. (2007). High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications. Clinical Cancer Research. 13(16). 4731–4739. 122 indexed citations

19.

Campbell, Ian, Sharoni Jacobs, Ella R. Thompson, & Kylie L. Gorringe. (2007). High resolution SNP array analysis of primary ovarian tumors reveals numerous microdeletions and amplifications.. Clinical Cancer Research. 13.

20.

Cristiano, Briony E., Katherine M. Hannan, Ian Campbell, et al.. (2006). A Specific Role for AKT3 in the Genesis of Ovarian Cancer through Modulation of G2-M Phase Transition. Cancer Research. 66(24). 11718–11725. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact